This finding extends the results of previous studies that have identified hypoalbuminemia (albumin range, 35–50 g/L) as a prognostic marker of 28–30-day [30, 39] and 2.5-year mortality [11] in patients with CAP to 5 years. This evidence concerns the gene ALB and Hypoalbuminemia.